A Green Fund exclusive interview with Dr. Richard Hopkins, Managing Director of Zelda Therapeutics. Zelda Therapeutics Ltd is an Australian-based bio-pharmaceutical company that aims to treat important diseases and disorders using cannabinoid-based medicines. Zelda Therapeutics – Pioneering Australian Medicinal Cannabis Research

Zelda Therapeutics Ltd (ASX:ZLD) is developing a range of cannabinoid-based formulations for the treatment of a variety of medical conditions, with a focus on cancer therapies. Zelda Therapeutics to outline cannabinoid-based strategy at Proactive CEO Sessions